BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vellayappan B, Tan CL, Yong C, Khor LK, Koh WY, Yeo TT, Detsky J, Lo S, Sahgal A. Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases. Front Oncol 2018;8:395. [PMID: 30324090 DOI: 10.3389/fonc.2018.00395] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Hong CS, Beckta JM, Kundishora AJ, Elsamadicy AA, Chiang VL. Laser interstitial thermal therapy for treatment of cerebral radiation necrosis. Int J Hyperthermia 2020;37:68-76. [PMID: 32672119 DOI: 10.1080/02656736.2020.1760362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Peker S, Samanci Y, Aygun MS, Yavuz F, Erden ME, Nokay AE, Atasoy Aİ, Bolukbasi Y. The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery. World Neurosurg 2021;146:e1134-46. [PMID: 33253956 DOI: 10.1016/j.wneu.2020.11.114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Akhoundova D, Hiltbrunner S, Mader C, Förster R, Kraft J, Schwanhäusser B, Bankel L, Kollias S, Treyer V, Rushing EJ, Lee SY, Andratschke N, Hüllner M, Curioni-Fontecedro A. 18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer. Clin Nucl Med 2020;45:113-7. [PMID: 31876831 DOI: 10.1097/RLU.0000000000002890] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bi N, Ma Y, Xiao J, Zhang H, Xu Y, Tian Y, Li J, Zhang Y, Liu Q, Wang K, Deng L, Wang W, Chen X, Liu F, Zhao R, Yang S, Huang X, Yi J, Hu C, Li Y. A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases. Oncologist 2019;24:e914-20. [PMID: 30996008 DOI: 10.1634/theoncologist.2018-0702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhu VW, Nagasaka M, Kubota T, Raval K, Robinette N, Armas O, Al-Holou W, Ou SI. Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases. Lung Cancer (Auckl) 2020;11:13-8. [PMID: 32021525 DOI: 10.2147/LCTT.S224991] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Newman WC, Goldberg J, Guadix SW, Brown S, Reiner AS, Panageas K, Beal K, Brennan CW, Tabar V, Young RJ, Moss NS. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes. J Neurooncol 2021;153:507-18. [PMID: 34146223 DOI: 10.1007/s11060-021-03790-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Co J, De Moraes MV, Katznelson R, Evans AW, Shultz D, Laperriere N, Millar BA, Berlin A, Kongkham P, Tsang DS. Hyperbaric Oxygen for Radiation Necrosis of the Brain. Can J Neurol Sci 2020;47:92-9. [PMID: 31466539 DOI: 10.1017/cjn.2019.290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
8 Gutzmer R, Vordermark D, Hassel JC, Krex D, Wendl C, Schadendorf D, Sickmann T, Rieken S, Pukrop T, Höller C, Eigentler TK, Meier F. Melanoma brain metastases - Interdisciplinary management recommendations 2020. Cancer Treat Rev 2020;89:102083. [PMID: 32736188 DOI: 10.1016/j.ctrv.2020.102083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Liao G, Khan M, Zhao Z, Arooj S, Yan M, Li X. Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review. Front Oncol 2021;11:593449. [PMID: 33842309 DOI: 10.3389/fonc.2021.593449] [Reference Citation Analysis]
10 Alnahhas I, Rayi A, Palmer JD, Raval R, Folefac E, Ong S, Giglio P, Puduvalli V. The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort study. Neurooncol Pract 2021;8:75-80. [PMID: 33664972 DOI: 10.1093/nop/npaa067] [Reference Citation Analysis]
11 Chen X, Parekh VS, Peng L, Chan MD, Redmond KJ, Soike M, McTyre E, Lin D, Jacobs MA, Kleinberg LR. Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgery. Neurooncol Adv 2021;3:vdab150. [PMID: 34901857 DOI: 10.1093/noajnl/vdab150] [Reference Citation Analysis]
12 Lehrer EJ, Prabhu AV, Sindhu KK, Lazarev S, Ruiz-Garcia H, Peterson JL, Beltran C, Furutani K, Schlesinger D, Sheehan JP, Trifiletti DM. Proton and Heavy Particle Intracranial Radiosurgery. Biomedicines 2021;9:31. [PMID: 33401613 DOI: 10.3390/biomedicines9010031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Miccio JA, Oladeru OT, Jun Ma S, Johung KL. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma. Urol Clin North Am 2020;47:399-411. [PMID: 32600541 DOI: 10.1016/j.ucl.2020.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Carr CM, Benson JC, DeLone DR, Diehn FE, Kim DK, Merrell KW, Nagelschneider AA, Madhavan AA, Johnson DR. Intracranial long-term complications of radiation therapy: an image-based review. Neuroradiology 2021;63:471-82. [PMID: 33392738 DOI: 10.1007/s00234-020-02621-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hainc N, Alsafwani N, Gao A, O'Halloran PJ, Kongkham P, Zadeh G, Gutierrez E, Shultz D, Krings T, Alcaide-Leon P. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery. J Neurooncol 2021. [PMID: 34689307 DOI: 10.1007/s11060-021-03879-4] [Reference Citation Analysis]
16 Helis CA, Hughes RT, Glenn CW, Lanier CM, Masters AH, Dohm A, Ahmed T, Ruiz J, Triozzi P, Gondal H, Cramer CK, Tatter SB, Laxton AW, Xing F, Lo HW, Su J, Watabe K, Wang G, Whitlow CT, Chan MD. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. International Journal of Radiation Oncology*Biology*Physics 2020;108:295-303. [DOI: 10.1016/j.ijrobp.2020.06.057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Loi M, Caini S, Scoccianti S, Bonomo P, De Vries K, Francolini G, Simontacchi G, Greto D, Desideri I, Meattini I, Nuyttens J, Livi L. Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis. Crit Rev Oncol Hematol 2020;153:103043. [PMID: 32650217 DOI: 10.1016/j.critrevonc.2020.103043] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sayan M, Şahin B, Mustafayev TZ, Kefelioğlu EŞS, Vergalasova I, Gupta A, Balmuk A, Güngör G, Ohri N, Weiner J, Karaarslan E, Özyar E, Atalar B. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases. Neurocirugia (Astur : Engl Ed) 2021;32:261-7. [PMID: 34743823 DOI: 10.1016/j.neucie.2020.08.007] [Reference Citation Analysis]
19 Lehrer EJ, McGee HM, Sheehan JP, Trifiletti DM. Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases. J Neurooncol 2021;151:75-84. [PMID: 32052355 DOI: 10.1007/s11060-020-03427-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sands JM, Daly ME, Lee EQ. Neurologic complications of lung cancer. Cancer 2020;126:4455-65. [PMID: 33460079 DOI: 10.1002/cncr.32772] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shi DD, Arnaout O, Bi WL, Buchbinder EI, Cagney DN, Insco ML, Liu D, Schoenfeld JD, Aizer AA. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy. World Neurosurg 2020;139:226-31. [PMID: 32330622 DOI: 10.1016/j.wneu.2020.04.087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
22 Kowalchuk RO, Niranjan A, Lee CC, Yang HC, Liscak R, Guseynova K, Tripathi M, Kumar N, Peker S, Samanci Y, Hess J, Chiang V, Iorio-Morin C, Mathieu D, Pikis S, Wei Z, Lunsford LD, Trifiletti DM, Sheehan JP. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02904-7. [PMID: 34644606 DOI: 10.1016/j.ijrobp.2021.10.008] [Reference Citation Analysis]
23 Skeie BS, Enger PØ, Knisely J, Pedersen PH, Heggdal JI, Eide GE, Skeie GO. A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria. Neurooncol Adv 2020;2:vdaa026. [PMID: 32642686 DOI: 10.1093/noajnl/vdaa026] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Matsuda R, Morimoto T, Tamamoto T, Inooka N, Ochi T, Miyasaka T, Hontsu S, Yamaki K, Miura S, Takeshima Y, Tamura K, Yamada S, Nishimura F, Nakagawa I, Motoyama Y, Park YS, Hasegawa M, Nakase H. Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed Brain Metastasis. Curr Oncol 2021;28:5255-65. [PMID: 34940078 DOI: 10.3390/curroncol28060439] [Reference Citation Analysis]
25 Sayan M, Mustafayev TZ, Balmuk A, Mamidanna S, Kefelioglu ESS, Gungor G, Chundury A, Ohri N, Karaarslan E, Ozyar E, Atalar B. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response. Radiat Oncol J 2020;38:176-80. [PMID: 33012145 DOI: 10.3857/roj.2020.00171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Voss M, Batarfi A, Steidl E, Wagner M, Forster MT, Steinbach JP, Rödel CM, Bojunga J, Ronellenfitsch MW. Adrenal Insufficiency in Patients with Corticosteroid-Refractory Cerebral Radiation Necrosis Treated with Bevacizumab. J Clin Med 2019;8:E1608. [PMID: 31623403 DOI: 10.3390/jcm8101608] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, Floyd SR, Torok JA, Salama JK, Sampson JH, Sperduto PW, Kirkpatrick JP. Current multidisciplinary management of brain metastases. Cancer 2020;126:1390-406. [PMID: 31971613 DOI: 10.1002/cncr.32714] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 10.5] [Reference Citation Analysis]
28 Sato A, Hiramoto A, Kim HS, Wataya Y. Anticancer Strategy Targeting Cell Death Regulators: Switching the Mechanism of Anticancer Floxuridine-Induced Cell Death from Necrosis to Apoptosis. Int J Mol Sci 2020;21:E5876. [PMID: 32824286 DOI: 10.3390/ijms21165876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Tran TT, Gallezot JD, Jilaveanu LB, Zito C, Turcu G, Lim K, Nabulsi N, Huang H, Huttner A, Kluger HM, Chiang VL, Carson R. [11C]Methionine and [11C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis. Mol Imaging 2020;19:1536012120968669. [PMID: 33147119 DOI: 10.1177/1536012120968669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tanenbaum DG, Buchwald ZS, Jhaveri J, Schreibmann E, Switchenko JM, Prabhu RS, Chowdhary M, Abugideiri M, Pfister NT, Eaton B, Kahn SE, Olson JJ, Shu HG, Crocker IR, Curran WJ, Patel KR. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases. Pract Radiat Oncol 2020;10:36-43. [PMID: 31586666 DOI: 10.1016/j.prro.2019.09.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
31 Tonse R, Tom MC, Mehta MP, Ahluwalia MS, Kotecha R. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases. Cancers (Basel) 2021;13:3682. [PMID: 34359583 DOI: 10.3390/cancers13153682] [Reference Citation Analysis]
32 Harrabi SB, von Nettelbladt B, Gudden C, Adeberg S, Seidensaal K, Bauer J, Bahn E, Mairani A, Alber M, Haberer T, Debus J, Herfarth K. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - How safe are protons? Radiother Oncol 2021;167:211-8. [PMID: 34973277 DOI: 10.1016/j.radonc.2021.12.035] [Reference Citation Analysis]
33 Weltman E, Kotecha R. Early-onset symptomatic radiation necrosis after stereotactic radiosurgery in the setting of COVID-19 infection. Med Dosim 2021:S0958-3947(21)00043-1. [PMID: 33910768 DOI: 10.1016/j.meddos.2021.04.002] [Reference Citation Analysis]
34 Sahgal A, Kellett S, Ruschin M, Greenspoon J, Follwell M, Sinclair J, Islam O, Perry J. A Cancer Care Ontario Organizational Guideline for the Delivery of Stereotactic Radiosurgery for Brain Metastasis in Ontario, Canada. Practical Radiation Oncology 2020;10:243-54. [DOI: 10.1016/j.prro.2019.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lee D, Riestenberg RA, Haskell-Mendoza A, Bloch O. Brain Metastasis Recurrence Versus Radiation Necrosis: Evaluation and Treatment. Neurosurg Clin N Am 2020;31:575-87. [PMID: 32921353 DOI: 10.1016/j.nec.2020.06.007] [Reference Citation Analysis]
36 Salvestrini V, Greco C, Guerini AE, Longo S, Nardone V, Boldrini L, Desideri I, De Felice F. The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO). Transl Oncol 2022;15:101275. [PMID: 34800918 DOI: 10.1016/j.tranon.2021.101275] [Reference Citation Analysis]
37 Lupattelli M, Alì E, Ingrosso G, Saldi S, Fulcheri C, Borghesi S, Tarducci R, Aristei C. Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis. J Pers Med 2020;10:E59. [PMID: 32635476 DOI: 10.3390/jpm10030059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Rahman R, Alexander BM, Wen PY. Neurologic Complications of Cranial Radiation Therapy and Strategies to Prevent or Reduce Radiation Toxicity. Curr Neurol Neurosci Rep 2020;20. [DOI: 10.1007/s11910-020-01051-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Travers S, Joshi K, Miller DC, Singh A, Nada A, Biedermann G, Cousins JP, Litofsky NS. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis. World Neurosurg 2021;151:e1059-68. [PMID: 34052453 DOI: 10.1016/j.wneu.2021.05.064] [Reference Citation Analysis]
40 Takamori S, Seto T, Jinnouchi M, Matsubara T, Haratake N, Miura N, Toyozawa R, Yamaguchi M, Takenoyama M. Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancer. Thorac Cancer 2020;11:2056-8. [PMID: 32469140 DOI: 10.1111/1759-7714.13494] [Reference Citation Analysis]
41 Wallerius K, Collins S, Forsthoefel M, Kim HJ. Increased Radiosurgery Toxicity Associated With Treatment of Vestibular Schwannoma in Multiple Sclerosis. Otol Neurotol 2021;42:e489-94. [PMID: 33351559 DOI: 10.1097/MAO.0000000000002977] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Riva G, Imparato S, Savietto G, Pecorilla M, Iannalfi A, Barcellini A, Ronchi S, Fiore MR, Paganelli C, Buizza G, Ciocca M, Baroni G, Preda L, Orlandi E. Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review. Br J Radiol 2021;94:20210524. [PMID: 34520670 DOI: 10.1259/bjr.20210524] [Reference Citation Analysis]
43 Lehrer EJ, Snyder MH, Desai BD, Li CE, Narayan A, Trifiletti DM, Schlesinger D, Sheehan JP. Clinical and radiographic adverse events after Gamma Knife radiosurgery for brainstem lesions: A dosimetric analysis. Radiother Oncol 2020;147:200-9. [PMID: 32413528 DOI: 10.1016/j.radonc.2020.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Nieblas-Bedolla E, Zuccato J, Kluger H, Zadeh G, Brastianos PK. Central Nervous System Metastases. Hematol Oncol Clin North Am 2022;36:161-88. [PMID: 34711458 DOI: 10.1016/j.hoc.2021.08.004] [Reference Citation Analysis]
45 Park M, Gwak HS, Lee SH, Lee YJ, Kwon JW, Shin SH, Yoo H. Clinical Experience of Bevacizumab for Radiation Necrosis in Patients with Brain Metastasis. Brain Tumor Res Treat 2020;8:93-102. [PMID: 32648383 DOI: 10.14791/btrt.2020.8.e11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mantovani C, Gastino A, Cerrato M, Badellino S, Ricardi U, Levis M. Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions. Front Oncol 2021;11:772789. [PMID: 34796118 DOI: 10.3389/fonc.2021.772789] [Reference Citation Analysis]
47 Berghoff AS, Breckwoldt MO, Riedemann L, Karimian-Jazi K, Loew S, Schlieter F, Furtner J, Cinci M, Thomas M, Strowitzki MJ, Marmé F, Michel LL, Schmidt T, Jäger D, Bendszus M, Preusser M, Wick W, Winkler F. Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases. Neurooncol Adv 2020;2:vdaa038. [PMID: 32642693 DOI: 10.1093/noajnl/vdaa038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Zhuang H, Tao L, Wang X, Shi S, Yuan Z, Wang E, Chang JY. Tyrosine Kinase Inhibitor Resistance Increased the Risk of Cerebral Radiation Necrosis After Stereotactic Radiosurgery in Brain Metastases of Non-small-Cell Lung Cancer: A Multi-Institutional Retrospective Case-Control Study. Front Oncol 2020;10:12. [PMID: 32117704 DOI: 10.3389/fonc.2020.00012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Carminucci A, Zeller S, Danish S. Radiographic Trends for Infield Recurrence After Radiosurgery for Cerebral Metastases. Cureus 2020;12:e8680. [PMID: 32699680 DOI: 10.7759/cureus.8680] [Reference Citation Analysis]
50 Garbacz M, Cordoni FG, Durante M, Gajewski J, Kisielewicz K, Krah N, Kopeć R, Olko P, Patera V, Rinaldi I, Rydygier M, Schiavi A, Scifoni E, Skóra T, Tommasino F, Rucinski A. Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors. Radiother Oncol 2021;163:143-9. [PMID: 34461183 DOI: 10.1016/j.radonc.2021.08.015] [Reference Citation Analysis]
51 Harada D, Takigawa N. Oligoprogression in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:5823. [PMID: 34830977 DOI: 10.3390/cancers13225823] [Reference Citation Analysis]
52 Jairam V, Park HS, Decker RH. Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. Cancer J 2020;26:129-36. [PMID: 32205537 DOI: 10.1097/PPO.0000000000000433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Cousins MM, Morris E, Maurino C, Devasia TP, Karnak D, Ray D, Parikh ND, Owen D, Ten Haken RK, Schipper MJ, Lawrence TS, Cuneo KC. TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy. Transl Oncol 2021;14:100950. [PMID: 33395747 DOI: 10.1016/j.tranon.2020.100950] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Rauch M, Tausch D, Stera S, Blanck O, Wolff R, Meissner M, Urban H, Hattingen E. MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics. J Neurooncol 2021;153:79-87. [PMID: 33761055 DOI: 10.1007/s11060-021-03744-4] [Reference Citation Analysis]
55 Sharma A, Kumar R. Metabolic Imaging of Brain Tumor Recurrence. AJR Am J Roentgenol 2020;215:1199-207. [PMID: 32960666 DOI: 10.2214/AJR.19.22624] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Cuccurullo V, Di Stasio GD, Cascini GL, Gatta G, Bianco C. The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence. Diagnostics (Basel) 2019;9:E127. [PMID: 31554255 DOI: 10.3390/diagnostics9040127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
57 Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, Raedt R, Vanhove C, De Vos F, Goethals I. 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. Nucl Med Biol 2020;82-83:9-16. [PMID: 31841816 DOI: 10.1016/j.nucmedbio.2019.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
58 Milano MT, Grimm J, Niemierko A, Soltys SG, Moiseenko V, Redmond KJ, Yorke E, Sahgal A, Xue J, Mahadevan A, Muacevic A, Marks LB, Kleinberg LR. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. Int J Radiat Oncol Biol Phys 2021;110:68-86. [PMID: 32921513 DOI: 10.1016/j.ijrobp.2020.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]